ArticleHaematologica2026

First-year results of the International Leukemia/ Lymphoma Target Board for pediatric relapsed and refractory hematological malignancies.

Uri Ilan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.